The Business Development and Strategy team at AbSci focuses on identifying and cultivating strategic partnerships and collaborations that enhance the company’s growth and innovation in drug and target discovery. Leveraging expertise in portfolio management and market trends, the team drives strategic initiatives, negotiates alliances, and develops pathways to commercialize AbSci's cutting-edge protein therapeutics, ultimately advancing their mission of harnessing AI and synthetic biology for transformative healthcare solutions.